UK health partnership deal a boon for new drug research
This article was originally published in Scrip
Executive Summary
The UK has a strong presence in clinical research, attracting a large share of the pharmaceutical industry's global R&D spending. But it is facing growing competition from emerging markets and other countries that are moving to shore up their clinical research base.